ZA964247B - Method of treating chronic progressive vascular diseases - Google Patents

Method of treating chronic progressive vascular diseases

Info

Publication number
ZA964247B
ZA964247B ZA964247A ZA964247A ZA964247B ZA 964247 B ZA964247 B ZA 964247B ZA 964247 A ZA964247 A ZA 964247A ZA 964247 A ZA964247 A ZA 964247A ZA 964247 B ZA964247 B ZA 964247B
Authority
ZA
South Africa
Prior art keywords
vascular diseases
treating chronic
chronic progressive
progressive vascular
treating
Prior art date
Application number
ZA964247A
Other languages
English (en)
Inventor
Gary E Striker
Liliane J Striker
Fred P Sherman
Original Assignee
Baker Norton Pharma
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baker Norton Pharma, Us Health filed Critical Baker Norton Pharma
Publication of ZA964247B publication Critical patent/ZA964247B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA964247A 1995-06-07 1996-05-27 Method of treating chronic progressive vascular diseases ZA964247B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/478,347 US5643892A (en) 1995-06-07 1995-06-07 Method of treating chronic progressive vascular diseases
BR9704114-9A BR9704114A (pt) 1995-06-07 1997-07-28 Processo de tratamento de doenças vasculares progressivas crÈnicas

Publications (1)

Publication Number Publication Date
ZA964247B true ZA964247B (en) 1996-12-04

Family

ID=25664870

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA964247A ZA964247B (en) 1995-06-07 1996-05-27 Method of treating chronic progressive vascular diseases

Country Status (14)

Country Link
US (1) US5643892A (xx)
EP (1) EP0809505B1 (xx)
AU (1) AU699012B2 (xx)
BR (1) BR9704114A (xx)
CA (1) CA2210351C (xx)
DE (1) DE809505T1 (xx)
ES (1) ES2115571T3 (xx)
HU (1) HUP9802431A3 (xx)
IL (1) IL121217A (xx)
NO (1) NO313686B1 (xx)
NZ (1) NZ309991A (xx)
TW (1) TW434018B (xx)
WO (1) WO1996040158A1 (xx)
ZA (1) ZA964247B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010005720A1 (en) * 1995-06-07 2001-06-28 U.S.A. As Represented By The Secretary Department Of Health And Human Services Method of treating chronic progressive vascular scarring diseases
US6255295B1 (en) 1996-12-23 2001-07-03 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue
UA65587C2 (en) 1997-10-09 2004-04-15 Baker Norton Pharma Method for preventing nephrotoxicity induced by cyclosporins or tacrolimus
DE19747195A1 (de) * 1997-10-24 1999-04-29 Knoll Ag Verwendung von Glykosaminoglykanen zur Herstellung von pharmazeutischen Zubereitungen zur Behandlung von mit Diabetes assoziierten Augenkrankheiten
WO2001052867A1 (en) * 2000-01-19 2001-07-26 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of pentosan polysulfate to treat certain conditions of the prostate
WO2007014155A2 (en) * 2005-07-22 2007-02-01 Trf Pharma, Inc. Method for treating sickle cell disease and sickle cell disease sequelae
DK2010220T3 (da) * 2006-04-03 2022-05-23 Ceva Animal Health Pty Ltd Stabiliserede pentosanpolysulfat-(pps)-formuleringer
EP2407174B1 (en) 2009-03-11 2014-05-07 Jellice Co., Ltd. Progression inhibitor or prophylactic agent for atherosclerosis, blood cholesterol level-lowering agent, and functional food or food for specified health uses
WO2011088418A2 (en) * 2010-01-15 2011-07-21 Mount Sinai School Of Medicine Inhibition of tnf-alpha induced activation of nfkb by pentosan polysulfate
JP6175431B2 (ja) 2011-06-20 2017-08-02 アイカーン スクール オブ メディシン アット マウント サイナイ ムコ多糖症およびその他のリソソーム障害に対する抗ｔｎｆ療法
US20130273096A1 (en) * 2011-10-05 2013-10-17 Bruce A. Daniels Therapeutic Sulfated Polysaccharides, Compositions Thereof, and Methods for Treating Patients
AU2018437600B2 (en) 2018-08-20 2022-11-17 Reqmed Company, Ltd. Novel pentosan polysulfate sodium preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820693A (en) * 1986-05-22 1989-04-11 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US4966890A (en) * 1986-04-04 1990-10-30 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
DE3725554A1 (de) * 1987-08-01 1989-02-09 Hoechst Ag Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung
US5032679A (en) * 1988-12-15 1991-07-16 Glycomed, Inc. Heparin fragments as inhibitors of smooth muscle cell proliferation
EP0466315A3 (en) * 1990-05-30 1992-07-01 Larrian Gillespie Compositions containing xylan sulphates for affecting growth factor function and for inhibiting fibroblast proliferation
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate

Also Published As

Publication number Publication date
WO1996040158A1 (en) 1996-12-19
EP0809505A4 (en) 1998-07-01
TW434018B (en) 2001-05-16
AU6030096A (en) 1996-12-30
NO313686B1 (no) 2002-11-18
AU699012B2 (en) 1998-11-19
EP0809505A1 (en) 1997-12-03
ES2115571T1 (es) 1998-07-01
HUP9802431A3 (en) 2001-06-28
ES2115571T3 (es) 2003-09-01
IL121217A (en) 2000-09-28
NO973081D0 (no) 1997-07-02
BR9704114A (pt) 2000-06-06
NZ309991A (en) 2001-03-30
IL121217A0 (en) 1999-10-28
NO973081L (no) 1997-08-27
EP0809505B1 (en) 2003-04-02
CA2210351A1 (en) 1996-12-19
HUP9802431A2 (hu) 1999-02-01
DE809505T1 (de) 1998-05-28
CA2210351C (en) 2003-09-23
US5643892A (en) 1997-07-01

Similar Documents

Publication Publication Date Title
IL117417A0 (en) Method of treating cardiac inflammatory disease
PL324284A1 (en) Methods of treating diabetes
ZA965088B (en) Methods of preventing or treating allergles
EP0746314A4 (en) METHOD FOR TREATING HYPERPROLIFERATIVE VASICAL DISEASE
EP0831924A4 (en) METHOD FOR TREATING ASTHMA
GB9620892D0 (en) Methods of treating RAF mediated diseases
AUPN271295A0 (en) Method of treatment
EP0729361A4 (en) METHOD FOR TREATING NEUROLOGICAL DISEASES
IL112590A0 (en) Novel method for treatment of renal diseases
EP0735054A3 (en) Process for the treatment of modified polymers
ZA964247B (en) Method of treating chronic progressive vascular diseases
PL327600A1 (en) Method of treating depressions
ZA982246B (en) Method of treating chronic progressive vascular scarring diseases
GB9515868D0 (en) Therapeutic method
EP0828507A4 (en) METHOD FOR TREATING PAIN
HUP9900138A3 (en) Method for treatment of wood element
GB9507825D0 (en) Method of treatment
EP0732938A4 (en) METHOD FOR TREATING INTESTINAL FAULTS
GB9415902D0 (en) Method of treatment
GB9407335D0 (en) Method of treatment
PL313573A1 (en) Method of enhancing a healing process of some chronic diseases
GB9502514D0 (en) Method of treatment
GB9500723D0 (en) Method of treatment
GB9523655D0 (en) Method of treatment
GB9500396D0 (en) Method of treatment